Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-104-6 | CAS number: 7439-95-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Comparable to guideline study with acceptable restrictions (not individual results reported), acceptable, well-documented publication/study report which meets basic scientific principles.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- GLP compliance:
- not specified
- Type of assay:
- mammalian cell gene mutation assay
- Target gene:
- Thymidine kinase (TK) +/- -3.7.2 heterozygote of L5178 mouse lymphoma cells
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- All cells were thawed from frozen stock and maintained in Fischer's medium for leukemic cells of mice containing 10% heat-inactivated horse serum, Pluronic F68, sodium pyruvate, penicillin G, and streptomycin sulfate.
Background spontaneous TK -/- mutant frequencies were reduced weekly by 24-h treatment of the cells with medium containing thymidine, hypoxanthene, methotrexate, and glycine. - Additional strain / cell type characteristics:
- other: TK +/-
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9
- Test concentrations with justification for top dose:
- 36,000 - 32,000 - 30,000 - 28,000 - 26,000 - 24,000 - 22,000 µg/ml.
- Vehicle / solvent:
- Sterile glass distilled water.
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- Migrated to IUCLID6: with and without S9 metabolic activation. EMS was purchased from Eastman Chemicals (Eastman Kodak, Rochester, N.Y.)
- Details on test system and experimental conditions:
- The test system was based on the procedure described by Clive et al. (1975, 1979) with modifications to the cloning procedure.
MgCl2 were diluted in sterile glass-distilled water, and 0.1 ml of dilution was added to a 10-ml suspension containing 6 X 10E6 cells from a culture recently cleansed of TK-/- cells. When testing with activation, the 10-ml suspension included 4 ml of an appropriate dilution of S9 with cofactor mix. Cultures containing either MgCl2, positive or solvent controls were incubated for 4 h at 37°C.
After exposure, the cells were washed twice, fresh medium was added, and the cultures were carried through a 2-day expression period. The cultures were counted after day 1 and readjusted to 3 X 10E5 cells per milliliter if necessary.
On day 2 a modified cloning procedure was followed. A sample from each culture was centrifuged and the cells resuspended at 500,000 viable cells per milliliter in Fischer's medium. The concentrated cells were serially diluted and appropriate dilutions plated in triplicate in cloning medium with and without trifluorothymidine (TFT). Approximately 500,000 viable cells (as determined by exclusion of trypan blue) were plated on each of three selective medium plates containing 2 Mg/ml TFT (Sigma), and 100 cells were cloned on each of three nonselective plates for each test and control tube. Cell inocula were added directly into 100-mm tissue culture plates, followed by the addition of about 30 ml cloning medium. The plates were swirled gently to ensure even dispersal of the inocula, allowed to gel, and then incubated at 37°C for approximately 12 d before they were counted. A New Brunswick Scientific automatic colony counter was used to determine the number of colonies per plate. - Evaluation criteria:
- Total survival was determined by the method of Clive and Spector (1975) which combines growth in suspension culture and soft cloning efficiency data.
The mutation frequency (MF) was calculated as the number of mutants per 105 colony-forming cells. - Statistics:
- no data
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Cytotoxicity observed at concentration of 28 mg/mL and above due to changes in osmotic pressure. See table in "any other information"
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- other: strain/cell type: Thymidine kinase +/-
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative
The in vitro gene mutation test in mouse lymphoma cells (thymidine kinase locus in L5178Y) on the test substance shown no treatment related increase in mutation frequency. - Executive summary:
MgCl2 was examined for its potential to induce forward mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. Test doses of MgCI2 evoked little or no enhancement of mutation compared to the solvent control. Only at 36,000 µg/ml was the response to mutation frequency greater than the solvant control, and this was at 1% total survival. These results were not altered by metabolic activation of the test system. While toxicity from exposure to MgCl2 might be related only to abnormal osmotic conditions, these results suggest that low survival levels (
Reference
Mutagenic responses of Mouse lymphoma L5178Y Cells following exposure to MgCl2
Chemical |
Dose (µg/ml) |
Percent total survival |
Mutation frequency |
Increase over solvant |
Solvent |
0 |
100 |
17.9 |
- |
EMS |
620 |
20 |
136.3 |
7.6 |
MgCl2 |
36,000 |
1 |
19.0 |
- |
|
32,000 |
15 |
13.3 |
- |
|
30,000 |
15 |
16.2 |
- |
|
28,000 |
46 |
15.6 |
- |
|
26,000 |
75 |
11.6 |
- |
|
24,000 |
101 |
13.1 |
- |
|
22,000 |
94 |
14.6 |
- |
|
|
|
|
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
In a reliable study (Oberly, T.J. et al.1982 ), the in vitro gene mutation test in mouse lymphoma cells (thymidine kinase locus in L5178Y) on the test substance show no increase in mutation frequency.
In a reliable study (Oguma Yet al.1998) magnesium sulfate induced no increase in the number of colonies with reverse mutation in any of the strains irrespective of the absence or presence of metabolic activation in the main study. Thus, it is concluded that magnesium sulfate does not have mutagenic potential under the presence experimental conditions.
The treatment of magnesium sulfate did not induce increases in the proportion of cells with structural and numerical aberrations both in the absence and the presence of metabolic activation system. It was concluded that magnesium sulfate did not exhibited clastogenic activity in cultured Chinese Hamster Lung cells when tested under the conditions employed for this test.
Justification for classification or non-classification
Based on the hazard assessment of Magnesium in section 2.1 and 2.2. in IUCLID 5.4., available data for the substance and following the “Guidance on Information Requirement and Chemical Safety Assessment R.8. Characterisation of dose [concentration]- response for human health” andaccording to the criteria described in Directive 67/548 and in the CLP Regulation:
Directive 67/548 |
Mutagenicity-Genetic Toxicity Muta. Cat. 1; R46 May cause heritable genetic damage. Muta. Cat. 2; R46 May cause heritable genetic damage. Muta. Cat. 3; R68 Possible risk of irreversible effects. |
CLP |
Germ cell mutagenicity Muta. 1A Muta. 1B Muta. 2 H340: May cause genetic defects <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>. H341: Suspected of causing genetic defects <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>. |
It is concluded that the substance Magnesium does not meet the criteria to be classified for human health hazards for Mutagenicity-Genetic Toxicity
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.